Target intelligence / Profile preview

Potassium channel subfamily K member 3 (TASK-1) (TASK-1)

Target
TASK-1
Molecular classification
Ion channel, Potassium channel, Two-pore domain potassium channel
01

Overview

Potassium channel subfamily K member 3 (TASK-1, encoded by the KCNK3 gene) is a member of the two-pore-domain potassium (K2P) channel family. It functions as an outwardly rectifying background or leak potassium channel that is highly sensitive to extracellular pH, hypoxia, and anesthetic agents. TASK-1 plays a critical role in stabilizing the resting membrane potential and regulating cellular excitability in various tissues, including atrial cardiomyocytes, pulmonary artery smooth muscle cells, and central neurons.

In disease states, upregulation of TASK-1 in atrial fibrillation leads to action potential duration shortening, making its inhibition a promising strategy for rhythm control. Conversely, loss-of-function mutations or downregulation of KCNK3 are strongly linked to the pathogenesis of pulmonary arterial hypertension (PAH) due to increased vasoconstriction and vascular remodeling. Pharmacological modulators of TASK-1 include inhibitors like doxapram and the investigational compound BAY 2586116, which are being evaluated for atrial fibrillation and obstructive sleep apnea, respectively. However, therapeutic targeting of TASK-1 requires careful management of safety concerns, particularly the risk of inducing pulmonary hypertension or systemic blood pressure elevation upon chronic channel blockade.

Other names
K2P3.1KCNK3TWIK-related acid-sensitive K+ channel 1Acid-sensitive potassium channel protein TASK-1Two pore potassium channel KT3.1
02

Mechanism of action

Inhibition of background potassium currents to prolong action potential duration and reduce cellular excitability (for atrial fibrillation and sleep apnea), or activation of the channel to hyperpolarize cells and induce vasodilation (for pulmonary arterial hypertension).

03

Biological functions

Potassium transportStabilization of membrane potentialRegulation of cell excitabilityCardiac conductionChemosensory respirationRegulation of aldosterone release
04

Disease associations

Atrial fibrillationPulmonary arterial hypertensionObstructive sleep apneaPrimary hyperaldosteronismLung adenocarcinoma
05

Safety considerations

Pulmonary arterial hypertension (due to chronic inhibition)Increased pulmonary artery pressureSystemic hypertension / increased blood pressureVentricular pro-arrhythmia (if selectivity is lost)Altered aldosterone secretion / hyperaldosteronism
06

Interacting drugs

11 more in the full profile.

07

Biomarkers

KCNK3 expression levelKCNK3 mutation statusHomocysteineAtrial action potential duration (APD)Atrial effective refractory period (AERP)

Beyond the preview

Go deeper on Potassium channel subfamily K member 3 (TASK-1) (TASK-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 3 (TASK-1) (TASK-1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call